Published in J Am Geriatr Soc on December 01, 1997
Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag (2008) 2.13
Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. CMAJ (1999) 1.60
Blood pressure variability and white matter hyperintensities in older adults with cardiovascular disease. Blood Press (2005) 1.05
Hypertension and cognitive function. Clin Geriatr Med (2009) 0.88
Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease. Biomed Res Int (2016) 0.77
Our "energy-Ca(2+) signaling deficits" hypothesis and its explanatory potential for key features of Alzheimer's disease. Front Aging Neurosci (2014) 0.77
Antihypertensive drugs and cognitive function in older people. J Am Geriatr Soc (1998) 0.75
Antihypertensive medications. J Am Geriatr Soc (1998) 0.75
Antihypertensive drugs, brain structure, and cognitive function: more research is necessary. J Am Geriatr Soc (1997) 0.75
In re hypertension and cognition: enough to be confused! J Am Geriatr Soc (2001) 0.75
Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci (2001) 42.21
The Cardiovascular Health Study: design and rationale. Ann Epidemiol (1991) 27.24
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med (2001) 12.29
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA (2000) 12.27
Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol (1995) 10.26
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation (1995) 9.13
Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics (1998) 8.48
Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA (1998) 8.21
Incidence of and risk factors for atrial fibrillation in older adults. Circulation (1997) 8.18
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol (1993) 7.49
The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA (1995) 7.31
Childhood and adult socioeconomic status as predictors of mortality in Finland. Lancet (1994) 6.02
Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA (1997) 5.91
Validating administrative data in stroke research. Stroke (2002) 5.90
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet (2000) 5.42
Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol (1985) (2001) 5.35
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
The messenger under attack -- intimidation of researchers by special-interest groups. N Engl J Med (1997) 5.14
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med (2000) 4.84
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens (1996) 4.66
Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med (2008) 4.64
Contributions of the history, physical examination, and laboratory investigation in making medical diagnoses. West J Med (1992) 4.62
Community-level comparisons between the grocery store environment and individual dietary practices. Prev Med (1991) 4.45
Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke (1991) 4.21
Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies. Diabetologia (2005) 4.19
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol (1994) 4.08
Measuring higher level physical function in well-functioning older adults: expanding familiar approaches in the Health ABC study. J Gerontol A Biol Sci Med Sci (2001) 4.01
Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2009) 3.91
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med (2004) 3.66
Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet (1998) 3.61
Are drugs within a class interchangeable? Lancet (1999) 3.58
JNC VI: timing is everything. Lancet (1997) 3.48
Measuring fitness in healthy older adults: the Health ABC Long Distance Corridor Walk. J Am Geriatr Soc (2001) 3.39
The clinical efficacy of magnetic resonance imaging in neuroimaging. Ann Intern Med (1994) 3.33
Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet (1996) 3.28
Time to act on drug safety. JAMA (1998) 3.22
Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia (2005) 3.20
Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology (2003) 3.14
Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology (2001) 3.07
Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med (1997) 3.05
Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med (1994) 3.04
Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology (2002) 2.98
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation (2000) 2.96
Aspartame ingestion and headaches: a randomized crossover trial. Neurology (1994) 2.91
British guidelines on managing hypertension. Provide evidence, progress, and an occasional missed opportunity. BMJ (1999) 2.83
Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol (2009) 2.79
The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis (1987) 2.77
Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol (1998) 2.77
Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol (1997) 2.76
Neighborhood socioeconomic disadvantage and mortality after stroke. Neurology (2013) 2.74
Subclinical disease as an independent risk factor for cardiovascular disease. Circulation (1995) 2.71
Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation (2000) 2.71
Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc (1999) 2.71
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med (2006) 2.55
Natural statins and stroke risk. Circulation (1999) 2.55
Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology (2001) 2.55
Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest (1999) 2.51
White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke (2004) 2.50
Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke (1996) 2.48
Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation (1998) 2.47
Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology (2010) 2.41
Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology (2001) 2.41
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Thromb Haemost (2007) 2.40
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet (2003) 2.37
Differences in sociodemographic, health status, and lifestyle characteristics among American Indians by telephone coverage. Prev Med (1994) 2.37
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
Elevated risk of stroke among patients with end-stage renal disease. Kidney Int (2003) 2.35
Potential problems with random zero sphygmomanometer. Lancet (1990) 2.31
Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ (1989) 2.27
The association between cholesterol and death from injury. Ann Intern Med (1994) 2.26
Family history as a risk factor for primary cardiac arrest. Circulation (1998) 2.25
Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern Med (2001) 2.24
Prevalence and correlates of snoring and observed apneas in 5,201 older adults. Sleep (1996) 2.23
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care (2000) 2.22
Predictors of maintaining cognitive function in older adults: the Health ABC study. Neurology (2009) 2.21
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA (1999) 2.21
Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study. JAMA (1992) 2.21